A Novel Carbohydrate Counting Smartphone App for Youth With Type 1 Diabetes
iSpy: A Pilot Randomized Control Trial of a Novel Carbohydrate Counting Smartphone App for Youth With Type 1 Diabetes
1 other identifier
interventional
46
1 country
1
Brief Summary
Type 1 Diabetes Mellitus (T1DM) is a common chronic disease of childhood. T1DM has substantial impact on quality of life (QOL), including burdensome dietary restrictions and the need to count carbohydrates in foods to safely dose insulin. Carbohydrate counting is challenging, inconvenient, and, if done wrong, can cause high or low blood glucose levels. To address these challenges, iSpy, a novel smartphone application, was created to identify foods and determine their carbohydrate content using pictures or speech. This pilot study is to evaluate if using iSpy improves carbohydrate counting accuracy and efficiency. Pilot participants will have carbohydrate counting (accuracy and efficiency) and their overall QoL (with respect to carbohydrate counting) assessed at baseline and after 3-months. The investigators hypothesize that using iSpy will make carbohydrate counting easier (by improving accuracy and efficiency) and enhance QoL for patients and/or their caregivers. If so, iSpy may help lessen the burden of living with T1DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2020
CompletedFirst Submitted
Initial submission to the registry
April 10, 2020
CompletedFirst Posted
Study publicly available on registry
April 21, 2020
CompletedApril 21, 2020
April 1, 2020
1.5 years
April 10, 2020
April 16, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Carbohydrate (CHO) Counting Accuracy
Assessing CHO counting using 10 food items from all major food groups. For each group, a simple food (e.g. an apple) and complex food (e.g. food with 2+ components but base food from targeted group) is included. A Co-investigator, Registered Dietitian (RD)/Certified Diabetes Educator (CDE), selected 2 sets of 10 food items for the study visits (verified that both sets were similar difficulty). The net CHO value (true value) for each food will be based on the nutrition label, USDA Nutrient Database (Release 28), Canadian Nutrient File, or by RD/CDE. For each food, data will be obtained from all participants: • Estimated net CHO (in grams) And with the above data, the following will be calculated: * % of food for which subjects estimated the CHO content within (+/-) 10 grams of true value. * Change (%) in the above accuracy measure for counting at baseline versus 3-month follow-up visit in iSpy vs control groups.
3 months
Carbohydrate (CHO) Counting Efficiency (Time to count)
Assessing CHO counting using 10 food items from all major food groups. For each group, a simple food (e.g. an apple) and complex food (e.g. food with 2+ components but base food from targeted group) is included. A Co-investigator, Registered Dietitian (RD)/Certified Diabetes Educator (CDE), selected 2 sets of 10 food items for the study visits (verified that both sets were similar difficulty). The net CHO value (true value) for each food will be based on the nutrition label, USDA Nutrient Database (Release 28), Canadian Nutrient File, or by RD/CDE. For each food, data will be obtained from all participants: • Time required to estimate net CHO (in seconds) In order to calculate the following: • Change in the above time taken for counting at baseline versus 3-month follow-up visit in iSpy vs control groups.
3 months
Secondary Outcomes (7)
Change in Quality of Life: Self Care Inventory Questionnaire
3 months
Change in Quality of Life: Diabetes Questionnaire
3 months
Change in Quality of Life: Quality of Life for Youth
3 months
Change in Quality of Life: Global Quality of Life
3 months
Implementation outcomes: Accrual/Attrition Rates
3 months
- +2 more secondary outcomes
Study Arms (2)
iSpy
EXPERIMENTALIn addition to usual care, participants in the intervention group will receive the iSpy intervention.
Control
NO INTERVENTIONThe control group participants will continue to use their usual method of carbohydrate counting for a 3-month period.
Interventions
iSpy is a novel healthcare application that hopes to address an important clinical need by facilitating carbohydrate counting using pictures or voice recognition. Proprietary algorithms adjust for portion size and identify hidden carbohydrates (such as in ketchup or other condiments) and quantify the amount of carbohydrates in a meal.
Eligibility Criteria
You may qualify if:
- Diagnosed with T1DM for ≥6 months;
- Completion of initial carbohydrate counting classes;
- Incorporating carbohydrate counting into treatment regimen;
- Having access to a smart phone and data plan;
You may not qualify if:
- Cognitive impairments or co-morbid physical or psychiatric condition (e.g. blindness, clinical depression, anxiety disorder) that might impact ability to use iSpy;
- Diagnosis of condition that affects dietary exposure (e.g. celiac disease);
- Participation in usability study;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Related Publications (1)
Alfonsi JE, Choi EEY, Arshad T, Sammott SS, Pais V, Nguyen C, Maguire BR, Stinson JN, Palmert MR. Carbohydrate Counting App Using Image Recognition for Youth With Type 1 Diabetes: Pilot Randomized Control Trial. JMIR Mhealth Uhealth. 2020 Oct 28;8(10):e22074. doi: 10.2196/22074.
PMID: 33112249DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Palmert
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chair of Pediatrics
Study Record Dates
First Submitted
April 10, 2020
First Posted
April 21, 2020
Study Start
July 12, 2018
Primary Completion
January 27, 2020
Study Completion
January 27, 2020
Last Updated
April 21, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share